Maximum Tolerated Dose: Clinical Trials

3 trials of Maximum Tolerated Dose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 terminated. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Active not recruiting 1, Completed 1, Terminated 1
Phase 23Active not recruiting 1, Completed 1, Terminated 1

Follow Maximum Tolerated Dose: new trials by email Literature Review of Maximum Tolerated Dose trials Research Report on Maximum Tolerated Dose

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
D,L-MEthadone and mFOLFOX6 in Treatment of Advanced Colorectal Cancer
Maximum tolerated dose, MTD: D,L-methadone hydrochloride (Methasan® 10 mg/ml) - Chemo-refractory Colorectal Carcinoma
Phase 1 / Phase 2Active not recruitingAIO-Studien-gGmbH112022-02-172025-10-03
Leronlimab (PRO 140) Combined With Carboplatin in Patients With Cytokine Chemokine Receptor 5 Positive (CCR5+) mTNBC
350 mg leronlimab, 525 mg leronlimab, 700 mg leronlimab - Triple Negative Breast Neoplasms
Phase 1 / Phase 2TerminatedCytoDyn, Inc.102019-04-222025-09-09
Study of Bendamustine and IXAZOMIB (MLN9708) Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma
MLN9708, Dexamethasone, Bendamustine (multiple dose levels) - Multiple Myeloma
Phase 1 / Phase 2CompletedParameswaran Hari382015-10-092020-10-22

Conditions studied

Colorectal Neoplasms (1)  ·  Multiple Myeloma (1)  ·  Triple Negative Breast Neoplasms (1)

Sponsors

AIO-Studien-gGmbH (1)  ·  CytoDyn, Inc. (1)  ·  Parameswaran Hari (1)

Countries

United States (2)  ·  Germany (1)

Top investigators

Jacob Lalezari, MD (1)  ·  Parameswaran Hari, MD, MRCP, MS (1)  ·  Thomas Seufferlein, Prof.Dr.med. (1)